During this webinar, Dr. Matt Kaeberlein provides an overview of translational geroscience, which he believes will become the paradigm for the practice of medicine in the 21st century. He also discusses his recent work with one such intervention, the drug rapamycin, and its potential to enhance healthspan in companion dogs and people.

Biological age is the greatest risk factor for nearly every major cause of death and disability, including COVID-19. Yet, traditional biomedical research and clinical approaches have generally focused on waiting until people are sick and treating individual diseases one at a time. Attempts to cure age-related diseases have proven unsuccessful, and the impact of “disease-first” approaches continue to be incremental. Recent advances in understanding them mechanisms linking biological aging to disease, or geroscience, have identified interventions that directly target the molecular hallmarks of aging. Unlike disease-specific approaches, such interventions have the potential to prevent multiple diseases of aging simultaneously, thereby greatly enhancing healthspan and lifespan for most individuals.

Key Topics Include:

  • Aging is a biological process that is under the control of both genetic and environmental factors
  • The biological mechanisms of aging are becoming better understood and can be formalized as nine “Hallmarks of Aging”
  • Several interventions have been identified that slow or reverse biological aging in laboratory animals
  • The drug rapamycin increases lifespan and reverses several functional declines associated with aging in mammals
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.

Resources

To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.

Presenters

Professor
Laboratory Medicine and Pathology
University of Washington

Dr. Matt Kaeberlein is a Professor of Laboratory Medicine and Pathology at the University of Washington School of Medicine. Dr. Kaeberlein’s research interests are focused on biological mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life.

Additional Content From American Physiological Society

Additional Content From Alliance for Aging Research

Aging and Skeletal Muscle Plasticity

Aging and Skeletal Muscle Plasticity

Join Sue Bodine, PhD for a deep dive into her research focused on the decline in muscle mass with aging and the role that innervation plays in muscle atrophy.

Related Content

Setup and Use of the 3-in-1 Whole Animal System

Setup and Use of the 3-in-1 Whole Animal System

The Aurora Scientific team will perform a live virtual demonstration of their 3-in-1 Whole Animal System, using a methodology focused overview of the 3 main experimental techniques for assessing contractility of whole muscle in murine models.